BORA PHARMACEUTICALS CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 713 TWD | -0.28% |
|
-4.42% | +11.58% |
Chart calendar Bora Pharmaceuticals Co., LTD.
e2901a8e1e86c.TBlt2-MlAHReb-i9iqRAyldPsnN-cAETY6DI-d5xt1U.I20PuZMVcyY7LtzozvEL_jUa6iFHPmIlE8iAqpYZ3BkJel_skGtxQh0Cmw~5489454605743f03373d90a37b418f6e
Upcoming events on Bora Pharmaceuticals Co., LTD.
Past events on Bora Pharmaceuticals Co., LTD.
| 08/05/2024 01:30 pm | April 2024 Sales and Revenue Release |
| 29/04/2024 | Extraordinary Shareholders Meeting |
| 09/04/2024 11:25 am | March 2024 Sales and Revenue Release |
| 21/03/2024 | Jefferies Asia Forum |
| 13/03/2024 11:30 am | Taishin Securities Investor Conference |
| 08/03/2024 05:47 am | February 2024 Sales and Revenue Release |
| 07/03/2024 03:12 pm | Q4 2023 Earnings Release |
| 15/02/2024 05:40 am | January 2024 Sales and Revenue Release |
| 09/01/2024 11:13 am | December 2023 Sales and Revenue Release |
Past dividends on Bora Pharmaceuticals Co., LTD.
| 06/07/2023 | Annual 8 TWD |
| 07/07/2022 | Annual 3.5 TWD |
| 07/09/2021 | Annual 2 TWD |
| 06/07/2020 | Annual 2 TWD |
| 31/07/2019 | Annual 3 TWD |
| 16/07/2018 | Annual 0.499519 TWD |
| 25/07/2017 | Annual 0.8 TWD |
| 18/07/2016 | Annual 0.601984 TWD |
| 03/09/2015 | Annual 0.5 TWD |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million TWD | Released Forecast Spread | 1 529 1 529 0.01% | 1 800 1 745 3.13% | 4 900 4 900 -0% | 10 494 10 401 0.9% | 14 200 14 195 0.04% | 18 427 |
|
EBITDA Million TWD | Released Forecast Spread | 464 524 -11.36% | 367 424 -13.42% | 1 256 1 453 -13.55% | 2 263 2 964 -23.67% | 5 855 5 844 0.2% | 6 007 |
|
EBIT Million TWD | Released Forecast Spread | 345 403 -14.43% | 226 273 -17.19% | 1 046 1 056 -0.95% | 1 922 2 404 -20.03% | 5 249 5 373 -2.31% | 5 536 |
|
Earnings before Tax (EBT) Million TWD | Released Forecast Spread | 325 389 -16.36% | 595 252 136.27% | 1 024 1 034 -0.97% | 1 840 2 543 -27.64% | 4 064 4 268 -4.77% | 4 346 |
|
Net income Million TWD | Released Forecast Spread | 305 350 -12.85% | 578 228 153.7% | 750 755 -0.7% | 1 392 1 803 -22.78% | 3 030 3 121 -2.92% | 3 215 |
|
EPS TWD | Released Forecast Spread | 3,41 4,45 -23.38% | 5,99 2,51 138.78% | 7,70 7,72 -0.27% | 14,1 18,4 -23.62% | 30,2 31,8 -4.98% | 31,7 |
| Announcement Date | 16/03/20 | 29/03/21 | 09/03/22 | 20/03/23 | 07/03/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million TWD | Released Forecast Spread | 1 150 1 150 -0.03% | 1 117 1 145 -2.42% | 1 355 1 208 12.19% | 2 724 2 036 33.8% | 5 298 5 205 1.8% | 4 781 4 970 -3.82% | 3 139 3 037 3.33% | 3 075 3 110 -1.1% | 3 206 3 201 0.14% | 2 857 | 5 062 | 5 203 | 5 436 | 5 225 |
|
EBITDA Million TWD | Released Forecast Spread | 238 275 -13.56% | 305 278 9.71% | 421 293 43.86% | 1 681 1 515 10.96% | 1 485 1 090 36.2% | 1 370 1 492 -8.2% | 1 320 1 281 3.05% | 1 293 | 1 609 | 1 788 | 2 037 | |||
|
EBIT Million TWD | Released Forecast Spread | 186 196 -4.96% | 252 224 12.31% | 369 242 52.98% | 643 445 44.57% | 658 1 140 -42.27% | 1 547 1 460 5.96% | 1 347 1 318 2.22% | 1 219 1 304 -6.51% | 1 320 1 263 4.56% | 1 004 | 1 411 | 1 548 | 1 588 | 1 526 |
|
Earnings before Tax (EBT) Million TWD | Released Forecast Spread | 182 193 -5.53% | 253 218 16.07% | 369 239 54.75% | 782 446 75.34% | 436 1 139 -61.71% | 1 442 1 443 -0.02% | 1 019 1 294 -21.25% | 923 1 031 -10.43% | 680 886 -23.27% | 699 | 1 096 | 1 233 | 1 274 | 1 276 |
|
Net income Million TWD | Released Forecast Spread | 140 145 -3.41% | 179 164 9.25% | 240 174 38.32% | 569 311 83.21% | 404 815 -50.42% | 1 039 1 183 -12.12% | 692 953 -27.38% | 733 659 11.21% | 566 660 -14.3% | 511 | 808 | 912 | 942 | 933 |
|
EPS TWD | Released Forecast Spread | 1,42 1,48 -4.25% | 1,83 1,67 9.2% | 2,46 1,77 38.86% | 5,81 3,04 90.99% | 4,00 8,33 -51.96% | 10,5 12,0 -12.41% | 8,81 9,32 -5.47% | 7,28 6,65 9.54% | 6,09 6,54 -6.92% | 5,03 | 7,96 | 8,98 | 9,28 | 9,22 |
| Announcement Date | 09/03/22 | 10/05/22 | 12/08/22 | 14/11/22 | 20/03/23 | 12/05/23 | 14/08/23 | 09/11/23 | 07/03/24 | - | - | - | - | - |
More events
Past sector events for Bora Pharmaceuticals Co., LTD.
| 10/05/2024 08:31 pm | PIRAMAL PHARMA LIMITED: Q4 2024 Earnings Release |
| 10/05/2024 04:20 pm | ANI PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
| 10/05/2024 04:16 pm | NEULAND LABORATORIES LIMITED: Q4 2024 Earnings Release |
| 10/05/2024 | NIPPON SHINYAKU CO., LTD.: Q4 2023 Earnings Release |
| 10/05/2024 | KYORIN PHARMACEUTICAL CO., LTD.: Q4 2023 Earnings Release |
| 10/05/2024 | JCR PHARMACEUTICALS CO., LTD.: Q4 2023 Earnings Release |
| 10/05/2024 | TTY BIOPHARM COMPANY LIMITED: Q1 2024 Earnings Release (Projected) |
| 10/05/2024 01:32 am | COLLEGIUM PHARMACEUTICAL, INC.: Q1 2024 Earnings Release |
| 09/05/2024 07:28 pm | SCINOPHARM TAIWAN, LTD.: April 2024 Sales and Revenue Release |
| 09/05/2024 06:36 pm | ABBOTT INDIA LIMITED: Q4 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- 6472 Stock
- Calendar Bora Pharmaceuticals Co., LTD.
